| 2026-04-03 |
复牌提示：
2026-04-02 19:50:00 停牌，复牌日期 2026-04-06 09:00:00
|
| 2026-04-01 |
详情>>
股本变动：
变动后总股本127.18万股
变动原因 ▼▲
- 原因：
- a 1-for-20 reverse stock split of its common stock
|
| 2026-04-01 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益0.25美元,归母净利润579.39万美元,同比去年增长491.12%
|
| 2025-11-18 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.07美元,归母净利润-160.99万美元,同比去年增长-120.71%
|
| 2025-08-15 |
股东大会：
将于2025-09-26召开股东大会
会议内容 ▼▲
- 1.To elect five directors nominated by HeartCore’s Board of Directors, based on the recommendation of HeartCore’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To ratify the appointment of MaloneBailey, LLP as HeartCore’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益-0.09美元,归母净利润-198.77万美元,同比去年增长39.48%
|
| 2025-05-29 |
详情>>
内部人交易：
Yasui Daishin共交易2笔
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.14美元,归母净利润-308.7万美元,同比去年增长-131.52%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-0.07美元,归母净利润-148.14万美元,同比去年增长64.64%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.37美元,归母净利润777.34万美元,同比去年增长681.52%
|
| 2024-08-23 |
股东大会：
将于2024-09-27召开股东大会
会议内容 ▼▲
- 1.To elect six directors nominated by HeartCore’s Board of Directors, based on the recommendation of HeartCore’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To approve the amendment of HeartCore’s certificate of incorporation to effectuate a reverse stock split of HeartCore’s outstanding shares of common stock, at a ratio of no less than 1-for-2 and no more than 1-for-10, with such ratio to be determined at the sole discretion of the Board;
3.To ratify the appointment of MaloneBailey, LLP as HeartCore’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
4.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.16美元,归母净利润-328.44万美元,同比去年增长-438.43%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.06美元,归母净利润-133.34万美元,同比去年增长-170.84%
|
| 2024-04-09 |
详情>>
业绩披露：
2023年年报每股收益-0.21美元,归母净利润-418.99万美元,同比去年增长37.25%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.07美元,归母净利润-133.67万美元,同比去年增长74.55%
|
| 2023-08-18 |
股东大会：
将于2023-09-29召开股东大会
会议内容 ▼▲
- 1.To elect seven directors nominated by HeartCore’s Board of Directors, based on the recommendation of HeartCore’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To approve the HeartCore Enterprises, Inc. 2023 Equity Incentive Plan;
3.To ratify the appointment of MaloneBailey, LLP as HeartCore’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
4.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2022-07-20 |
股东大会：
将于2022-08-16召开股东大会
会议内容 ▼▲
- 1.To elect seven directors nominated by HeartCore’s Board of Directors, based on the recommendation of HeartCore’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To hold a non-binding advisory vote on executive compensation;
3.To hold a non-binding advisory vote on the frequency of executive compensation advisory votes;
4.To ratify the appointment of MaloneBailey, LLP as HeartCore’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
5.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|